RIA
ABBV icon

Regal Investment Advisors’s AbbVie ABBV Stock Holding History

Regal Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Sell
71,921
-466
-0.6% -$103K 0.9% 18
2025
Q4 		$16.5M Buy
72,387
+1,312
+2% +$299K 0.99% 18
2025
Q3 		$16.5M Sell
71,075
-7,644
-10% -$1.56M 1.07% 13
2025
Q2 		$14.6M Buy
78,719
+842
+1% +$156K 1.1% 14
2025
Q1 		$16.3M Sell
77,877
-36,902
-32% -$7.17M 1.32% 11
2024
Q4 		$20.4M Buy
114,779
+3,032
+3% +$557K 1.53% 9
2024
Q3 		$22.1M Buy
111,747
+2,716
+2% +$507K 1.55% 7
2024
Q2 		$18.7M Buy
109,031
+3,008
+3% +$498K 1.22% 12
2024
Q1 		$19.3M Sell
106,023
-5,701
-5% -$983K 1.32% 9
2023
Q4 		$17.3M Sell
111,724
-1,372
-1% -$200K 1.31% 11
2023
Q3 		$16.9M Buy
113,096
+4,445
+4% +$653K 1.42% 10
2023
Q2 		$14.6M Sell
108,651
-1,807
-2% -$265K 1.23% 12
2023
Q1 		$17.6M Buy
110,458
+7,382
+7% +$1.13M 1.55% 7
2022
Q4 		$16.7M Buy
103,076
+3,447
+3% +$529K 1.61% 6
2022
Q3 		$13.4M Buy
99,629
+5,155
+5% +$740K 1.41% 12
2022
Q2 		$14.5M Buy
94,474
+1,244
+1% +$190K 1.51% 10
2022
Q1 		$15.1M Sell
93,230
-6,046
-6% -$878K 1.39% 11
2021
Q4 		$13.4M Sell
99,276
-2,733
-3% -$323K 1.19% 13
2021
Q3 		$11M Buy
102,009
+2,102
+2% +$240K 1.07% 15
2021
Q2 		$11.3M Buy
+99,907
New +$11.3M 1.13% 11
2021
Q1 		– Sell
-112,968
Closed -$12.1M – 30
2020
Q4 		$12.1M Buy
+112,968
New +$10.9M 1.37% 13
2020
Q1 		– Sell
-97,162
Closed -$8.6M – 29
2019
Q4 		$8.6M Sell
97,162
-2,416
-2% -$201K 1.55% 11
2019
Q3 		$7.54M Sell
99,578
-952
-0.9% -$65.3K 1.47% 13
2019
Q2 		$7.31M Buy
100,530
+5,410
+6% +$425K 1.42% 13
2019
Q1 		$7.67M Buy
95,120
+5,816
+7% +$476K 1.56% 10
2018
Q4 		$8.23M Buy
89,304
+4,521
+5% +$398K 1.8% 4
2018
Q3 		$8.02M Buy
84,783
+30,728
+57% +$2.91M 1.69% 5
2018
Q2 		$5.01M Sell
54,055
-22,529
-29% -$2.2M 1.52% 9
2018
Q1 		$7.25M Sell
76,584
-4,411
-5% -$485K 1.6% 8
2017
Q4 		$7.83M Sell
80,995
-3,733
-4% -$352K 1.75% 5
2017
Q3 		$7.53M Buy
84,728
+5,868
+7% +$447K 1.76% 5
2017
Q2 		$5.72M Buy
78,860
+106
+0.1% +$7.13K 1.42% 7
2017
Q1 		$5.13M Buy
78,754
+4,257
+6% +$268K 1.34% 10
2016
Q4 		$4.67M Buy
74,497
+4,016
+6% +$245K 1.29% 10
2016
Q3 		$4.45M Buy
70,481
+3,876
+6% +$251K 1.26% 11
2016
Q2 		$4.12M Sell
66,605
-100
-0.1% -$6.09K 1.13% 15
2016
Q1 		$3.81M Buy
66,705
+1,737
+3% +$96.8K 1.03% 22
2015
Q4 		$3.85M Buy
64,968
+10,631
+20% +$612K 1% 20
2015
Q3 		$2.96M Buy
54,337
+1,947
+4% +$127K 0.77% 34
2015
Q2 		$3.52M Buy
52,390
+647
+1% +$42.2K 0.95% 20
2015
Q1 		$3.03M Buy
51,743
+5,577
+12% +$337K 0.75% 35
2014
Q4 		$3.02M Sell
46,166
-3,297
-7% -$208K 0.81% 27
2014
Q3 		$2.86M Buy
49,463
+2,819
+6% +$157K 0.86% 26
2014
Q2 		$2.63M Buy
46,644
+9,776
+27% +$513K 0.94% 16
2014
Q1 		$1.9M Buy
36,868
+9,450
+34% +$478K 0.8% 47
2013
Q4 		$1.45M Sell
27,418
-769
-3% -$37.8K 0.83% 40
2013
Q3 		$1.26M Buy
28,187
+6,897
+32% +$306K 0.74% 35
2013
Q2 		$880K Buy
+21,290
New +$931K 0.49% 71

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Regal Investment Advisors's ABBV Position: Q1 2026 in Review

Regal Investment Advisors reduced its AbbVie (ABBV) stake by 0.64% in Q1 2026, selling an estimated $103K and leaving 71,921 shares worth $15.6M. The position accounts for 0.9% of the portfolio, ranked #18.

Regal Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $22.1M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Regal Investment Advisors held 71,921 shares of AbbVie worth $15.6M as of Q1 2026.
  • Regal Investment Advisors sold 466 AbbVie shares in Q1 2026, an estimated $103K.
  • AbbVie made up 0.9% of Regal Investment Advisors's portfolio in Q1 2026, its #18 holding.
  • Regal Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
  • Regal Investment Advisors's AbbVie position peaked at $22.1M in Q3 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.